Are you prepared to address the nutritional implications of GLP-1 therapies and their impact on obesity management?
IQVIA Consumer Health’s latest whitepaper provides the insights you need to understand why nutrition is central to patient outcomes and market growth in this new era of obesity care.
Developed by IQVIA Consumer Health experts, it explores:
- How GLP-1 receptor agonists change nutrient intake, absorption, and long-term health outcomes.
- The clinical impact of nutrient deficiencies, lean mass loss, and reduced quality of life in GLP-1 RA users.
- Evidence-based nutritional strategies to optimize results and safeguard patient health.
- The critical role - and opportunity - for the medical nutrition industry in shaping the future of obesity treatment.
Complete the form on this page to download the whitepaper and understand why nutrition is the keystone of obesity management in the GLP-1 era.
